STABILITY OF A NOVEL DITHRANOL OINTMENT FORMULATION, CONTAINING ASCORBYL PALMITATE AS AN ANTI-OXIDANT
- 28 June 2008
- journal article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 15 (6), 419-423
- https://doi.org/10.1111/j.1365-2710.1990.tb00406.x
Abstract
An emulsifying ointment-based dithranol formulation is described which was, with the addition of 0.1% w/w ascorbyl palmitate, stable for 52 weeks at room temperature. This is in contrast to the more conventionally used dithranol in Lassar's paste, which is stable for only 4 weeks at room temperature. An emulsifying ointment-based paste was additionally more convenient to use since it was easier to apply and remove.Keywords
This publication has 10 references indexed in Scilit:
- Simplified dithranol treatment for psoriasis*British Journal of Dermatology, 2006
- Short contact dithranol therapy: advantages of a stiff emulsifying ointment baseBritish Journal of Dermatology, 2006
- PsoriasisBritish Journal of Dermatology, 1988
- Anthralin stability in various vehiclesJournal of the American Academy of Dermatology, 1987
- Anthralin: Historical and current perspectivesJournal of the American Academy of Dermatology, 1983
- Pharmaceutical formulations of anthralinBritish Journal of Dermatology, 1981
- Anthralin oxidation products: role of the C10-methylene and phenol groupsBritish Journal of Dermatology, 1981
- Cyclosporin a for PsoriasisNew England Journal of Medicine, 1979
- THE TREATMENT OF PSORIASIS WITH TRIACETOXYANTHRACENEBritish Journal of Dermatology, 1967
- The Approach to PsoriasisBMJ, 1953